Aberrant DNA methylation is closely associated with cellular dysfunctions in lung cancer, such as DNA repair (O6 methylguanine DNA methyltransferase, MGMT), cell growth (Short State Homebox2, SHOX2), and cell cycle (cycling dependent kinase inhibitor 2A, CDKN2A). Here, SHOX2 is linked to lung cancer.